Boston, MA -- (SBWIRE) -- 03/23/2017 -- Stem cell therapy is the use of stem cells for the treatment or prevention of a disease or condition. Bone marrow transplant is the widely-used stem cell therapy, followed by therapies derived from umbilical cord blood. Research is being undertaken to develop various sources (such as cord blood cells, bone marrow, and skin) for stem cells, and to apply them to various disorders like neurodegenerative diseases and conditions such as heart disease, diabetes, and other conditions.

Technavio's analysts forecast the global stem cell therapy market to grow at a CAGR of 36.52% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global stem cell therapy market for 2017-2021. To calculate the market size, the report considers the sales of stem cell therapy products/segments in the market.

Get More Details on this Report and a Full Table of Contents at Global Stem Cell Therapy Market 2017-2021

The market is divided into the following segments based on geography:

-Americas
-APAC
-EMEA

Technavio's report, Global Stem Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-Holostem Advanced Therapies
-JCR Pharmaceuticals
-Organogenesis
-Osiris Therapeutics
-Vericel

Other prominent vendors

-AbbVie
-American CryoStem
-AM-Pharma
-Anterogen
-apceth Biopharma
-Astellas Pharma
-Athersys
-Baxter International
-Beike Biotechnology
-BIOTIME
-bluebird bio
-Bristol-Myers Squibb
-BrainStorm Cell Therapeutics
-Brainxell
-Caladrius Biosciences
-Cellular Biomedicine Group
-Cellular Dynamics International (a subsidiary of Fujifilm)
-Cesca Therapeutics
-CHA Biotech
-Chugai Pharmaceutical
-Citospin
-Corestem
-Cytori Therapeutics
-Daiichi Sankyo
-Fujifilm
-Gamida Cell
-Global Stem Cells Group
-Grupo Ferrer Internacional
-GlaxoSmithKline
-Hemostemix
-Histocell
-International Stem Cell
-Ivy Institute of Stem Cells
-Japan Regenerative Medicine
-Kangstem Biotech
-Kiadis Pharma
-Laboratorios Salvat
-MEDIPOST
-Mesoblast
-Nuo Therapeutics
-Opsis Therapeutics
-Osiris Therapeutics
-Pharmicell
-Pluristem Therapeutics
-Promethera Biosciences
-Q Therapeutics
-ReNeuron
-RHEACELL
-Salus Medical Solutions
-Sangamo Therapeutics
-Shire
-Steminent Biotherapeutics
-Sumitomo Dainippon Pharma
-Taiwan Bio Therapeutics
-Takeda Pharmaceutical
-Teva Pharmaceutical Industries
-Thoratec Corporation
-TiGenix
-Translational Biosciences
-TWO CELLS
-U.S. Stem Cell
-ViaCyte
-VistaGen Therapeutics

Market driver

-Increase in federal funding in stem cell therapy
-For a full, detailed list, view our report

Market challenge

-Stringent regulatory environment affecting the product approvals
-For a full, detailed list, view our report

Market trend

-Evolution of new destinations in the development of stem cell therapies
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2021 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: Holostem Advanced Therapies, JCR Pharmaceuticals, Organogenesis, Osiris Therapeutics, Vericel, AbbVie, American CryoStem, AM-Pharma, Anterogen, apceth Biopharma, Astellas Pharma, Athersys, Baxter International, Beike Biotechnology, BIOTIME, bluebird bio, Bristol-Myers Squibb, BrainStorm Cell Therapeutics, Brainxell, Caladrius Biosciences, Cellular Biomedicine Group, Cellular Dynamics International (a subsidiary of Fujifilm), Cesca Therapeutics, CHA Biotech, Chugai Pharmaceutical, Citospin, Corestem, Cytori Therapeutics, Daiichi Sankyo, Fujifilm, Gamida Cell, Global Stem Cells Group, Grupo Ferrer Internacional, GlaxoSmithKline, Hemostemix, Histocell, International Stem Cell, Ivy Institute of Stem Cells, Japan Regenerative Medicine, Kangstem Biotech, Kiadis Pharma, Laboratorios Salvat, MEDIPOST, Mesoblast, Nuo Therapeutics, Opsis Therapeutics, Osiris Therapeutics, Pharmicell, Pluristem Therapeutics, Promethera Biosciences, Q Therapeutics, ReNeuron, RHEACELL, Salus Medical Solutions, Sangamo Therapeutics, Shire, Steminent Biotherapeutics, Sumitomo Dainippon Pharma, Taiwan Bio Therapeutics, Takeda Pharmaceutical, Teva Pharmaceutical Industries, Thoratec Corporation, TiGenix, Translational Biosciences, TWO CELLS, U.S. Stem Cell, ViaCyte, VistaGen Therapeutics

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Biotechnology research reports at Fast Market Research

You may also be interested in these related reports:

-Stem Cell Assay Market - Forecast to 2021
-Global Stem Cell Partnering 2010-2016: Deal trends, players, financials and forecasts
-Regenerative Medicines Market - Global Forecast to 2021
-Global Regenerative Medicine Market 2016-2020
-Cell Expansion Market - Global Forecasts to 2021